SCHEMBL6537459

SCHEMBL6537459

CS(=O)(=O)NNc1ccnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 8/20 0.49
JAK2 O60674 6/20 0.49
JAK1 P23458 5/20 0.49
KDR P35968 1/20 0.42
MAP4K4 O95819 1/20 0.41
CSNK2A1 P68400 1/20 0.41
HIPK4 Q8NE63 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
CYP3A4 P08684 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 2/20 0.40
HTT P42858 2/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40
PLA2G7 Q13093 1/20 0.40
SLC40A1 Q9NP59 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537420 0.89 TYK2 (0.47) TYK2JAK2JAK1KDRSMN1; SMN2
SCHEMBL6538121 0.87 TYK2 (0.46) TYK2JAK2JAK1MAPT
SCHEMBL6537767 0.86 TYK2 (0.53) TYK2JAK2JAK1KDRMAP4K4
SCHEMBL6538149 0.86 SLC40A1 (0.50) TYK2JAK2JAK1KDRMAP4K4
SCHEMBL6538203 0.86 TYK2 (0.55) TYK2JAK2JAK1KDRMAP4K4
SCHEMBL6537638 0.86 KMT2A (0.49) TYK2JAK2JAK1SMN1; SMN2KDM4E
SCHEMBL6538207 0.84 TYK2 (0.51) TYK2JAK2JAK1KDRMAP4K4
SCHEMBL6537858 0.83 JAK2 (0.44) TYK2JAK2JAK1KDRSMN1; SMN2
SCHEMBL6537991 0.83 MMP2 (0.44) TYK2JAK2JAK1KDRSMN1; SMN2
SCHEMBL6537461 0.82 TYK2 (0.57) TYK2JAK2JAK1KDRMAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed